Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 20 symbols : LLY save search
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published: 2021-05-20 (Crawled : 18:26) - fda.gov
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: 0.22%
H: 0.97%
C: -0.65%
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: 0.24%
H: 0.96%
C: -0.06%
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
ADCT | $4.78 -3.82% 2.3% 19
|
Health Technology
|
| O: 2.54%
H: 0.48%
C: -0.29%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 0.35%
H: 0.65%
C: -1.19%
YMAB | $15.29 -0.33% -0.52% 160K
|
Health Technology
|
| O: 0.58%
H: 1.24%
C: -1.66%
VSTM | $9.31 -3.12% -3.44% 79K
|
Health Technology
|
| O: 0.63%
H: 2.49%
C: -0.62%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -0.43%
H: 0.2%
C: 0.02%
RIGL | $1.125 -1.32% -1.33% 6.5M
|
Health Technology
|
| O: 0.82%
H: 1.08%
C: -1.62%
REGN | News | $906.54 -0.09% -0.08% 280K
|
Health Technology
|
| O: 0.18%
H: 0.46%
C: -1.44%
KPTI | $1.09 0.91% 8
|
Health Technology
|
| O: 0.31%
H: 1.15%
C: -1.46%
INCY | $51.74 0.17% 0.14% 2
|
Health Technology
|
| O: 0.57%
H: 0.6%
C: -1.46%
ILMN | $122.87 -1.28% -1.4% 330
|
Health Technology
|
| O: 0.33%
H: 2.2%
C: 0.21%
EXEL | $23.71 1.8% 1.73% 12
|
Health Technology
|
| O: 0.08%
H: 1.64%
C: 0.45%
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: -2.62%
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 0.95%
H: 1.31%
C: -2.81%
BPMC | $92.26 -0.03% 0.02% 590K
|
Health Technology
|
| O: 1.12%
H: 0.84%
C: -0.08%
BGNE | $144.12 3.69% 3.48% 150
|
Health Technology
|
| O: 0.1%
H: 1.6%
C: 0.88%
AVEO | $15.0 0.0% 0
|
Health Technology
|
| O: 1.19%
H: 1.71%
C: -0.33%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.71%
H: 0.14%
C: -1.06%
ALNY | $143.8 -1.55% -1.58% 400K
|
Health Technology
|
| O: 0.38%
H: 1.01%
C: -0.41%
AGIO | $31.67 -0.44% -0.44% 640K
|
Health Technology
|
| O: 0.86%
H: 1.27%
C: -0.24%
cancer approval
Atea Pharmaceuticals Appoints Jerome Adams, M.D., M.P.H., to Board of DirectorsFormer U.S. Surgeon General Brings Wealth of Clinical and Public Health Experience
Published: 2021-05-20 (Crawled : 13:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: 0.33%
H: 1.99%
C: 1.2%
AVIR | $3.7 -0.8% -0.67% 200K
|
Health Technology
|
| O: 0.5%
H: 6.73%
C: 5.89%
Lilly's tirzepatide achieves all primary and key secondary study outcomes against insulin glargine in adults with type 2 diabetes and increased cardiovascular risk in SURPASS-4 trial
Published: 2021-05-20 (Crawled : 11:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: 0.33%
H: 1.99%
C: 1.2%
diabetes risk cardiovascular insulin cardio trial glargine tirzepatide
Arecor Announces an Exclusive Formulation Study Collaboration With Lilly
Published: 2021-05-20 (Crawled : 10:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: 0.33%
H: 1.99%
C: 1.2%
collaboration
HUTCHMED Highlights Clinical Data to be Presented at the Upcoming ASCO21 Virtual Scientific Program
Published: 2021-05-20 (Crawled : 10:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.71% 8K
|
Health Technology
|
| O: 0.33%
H: 1.99%
C: 1.2%
AZN | News | $71.2 0.49% 0.46% 300K
|
Health Technology
|
| O: 1.12%
H: 1.16%
C: 0.82%
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
MTH | $154.69 -2.21% 7.56% 64
|
Consumer Durables
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
IHT P | $1.3712 0.82% 6.48% 0
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.